Keyword: CureVac


CureVac Presents Positive Data from mRNA Trials

01.02.2023 -

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...


CureVac and GSK launch Phase 1 for Covid Booster

23.08.2022 -

CureVac and GSK have announced they are launching a Phase 1 clinical trial with their modified mRNA-based Covid 19 vaccine CV051, which would be recommended as a booster...


Pfizer and BioNTech Counter CureVac Lawsuit

03.08.2022 -

Pfizer and BioNTech are fighting back against CureVac’s lawsuit that asserts the makers of the Comirnaty-branded mRNA vaccine for Covid-19 infringed its patent.


CureVac Sues BioNTech for IP Infringement

07.07.2022 -

Germany’s BioNTech is pushing back against allegations by compatriot CureVac that the company infringed its intellectual property in formulating its mRNA-based Covid-19...


FDA Panel Recommends Approval of Nuaxovid

09.06.2022 -

In a vote of 21 in favor with one abstention, the US Food and Drug Administration’s advisory panel has recommended that the FDA approve Novavax’s Covid-19 vaccine...

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Six Firms to Make Vaccines for German Emergency Supply

12.04.2022 -

Germany’s economics ministry has budgeted up to €2.9 billion ($3.14 billion) to ensure sufficient supply of mostly mRNA-based Covid-19 vaccines to be able to deal with...


CureVac Pulls CVnCov from EMA Approval Process

13.10.2021 -

CureVac is withdrawing its first-generation Covid-19 vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency. In a statement, the...